生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Ramipril is a angiotensin converting enzyme (ACE) inhibitor. Ramipril benefited left ventricular remodeling by reducing fibrosis and collagen accumulation in the left ventricle of rats after myocardial infarction[3]. Ramipril inhibits systolic blood pressure (SBP) with IC50 of 1.97 mg/kg in spontaneously hypertensive rats (SHR). Cardiac ACE activity was greatly reduced by ramipril independently of SBP reduction and dosage[4]. Prolonged ramiprilat treatment increased ACE expression in primary cultures of human endothelial cells and in vivo (mouse lung) [5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00732069 | End Stage Renal Failure on Dia... 展开 >>lysis Complication of Hemodialysis 收起 << | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37323 收起 << |
NCT00732069 | - | Completed | - | - | |
NCT01225445 | Biopsy-confirmed IgA Nephropat... 展开 >>hy Proteinuria Less Than 0.5 g Per Day Normal Blood Pressure Serum Creatinine Below 120 Umol/l 收起 << | Phase 3 | Completed | - | Hong Kong ... 展开 >> Department of Medicine & Therapeutics, Prince of Wales Hospital Shatin, Hong Kong 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.40mL 0.48mL 0.24mL |
12.00mL 2.40mL 1.20mL |
24.01mL 4.80mL 2.40mL |
参考文献 |
---|